171 related articles for article (PubMed ID: 14977116)
1. Efficacy of VectoBac (Bacillus thuringiensis variety israelensis) formulations for mosquito control in Australia.
Russell TL; Brown MD; Purdie DM; Ryan PA; Kay BH
J Econ Entomol; 2003 Dec; 96(6):1786-91. PubMed ID: 14977116
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of VectoLex (Bacillus sphaericus) products to selected Australian mosquito and nontarget species.
Brown ID; Watson TM; Carter J; Purdie DM; Kay BH
J Econ Entomol; 2004 Feb; 97(1):51-8. PubMed ID: 14998127
[TBL] [Abstract][Full Text] [Related]
3. Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species.
Nayar JK; Knight JW; Ali A; Carlson DB; O'Bryan PD
J Am Mosq Control Assoc; 1999 Mar; 15(1):32-42. PubMed ID: 10342266
[TBL] [Abstract][Full Text] [Related]
4. Indoor thermal fogging against vector mosquitoes with two Bacillus thuringiensis israelensis formulations, Vectobac ABG 6511 water-dispersible granules and Vectobac 12AS liquid.
Yap HH; Lee YW; Zairi J
J Am Mosq Control Assoc; 2002 Mar; 18(1):52-6. PubMed ID: 11998931
[TBL] [Abstract][Full Text] [Related]
5. Laboratory and field evaluation of efficacy of VectoBac 12AS against Culex sitiens (Diptera: Culicidae) larvae.
Brown MD; Thomas D; Watson K; Kay BH
J Am Mosq Control Assoc; 1998 Jun; 14(2):183-5. PubMed ID: 9673920
[TBL] [Abstract][Full Text] [Related]
6. Integration of Bacillus thuringiensis H-14 formulations and pyriproxyfen for the control of larvae of Aedes aegypti and Aedes albopictus.
Lee YW; Zairi J; Yap HH; Adanan CR
J Am Mosq Control Assoc; 2005 Mar; 21(1):84-9. PubMed ID: 15825767
[TBL] [Abstract][Full Text] [Related]
7. Laboratory and simulated field evaluation of a new recombinant of Bacillus thuringiensis ssp. israelensis and Bacillus sphaericus against Culex mosquito larvae (Diptera: Culicidae).
Zahiri NS; Federici BA; Mulla MS
J Med Entomol; 2004 May; 41(3):423-9. PubMed ID: 15185945
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of liquid Bacillus thuringiensis var. israelensis products for control of Australian Aedes arbovirus vectors.
Brown MD; Carter J; Watson TM; Thomas P; Santaguliana G; Purdie DM; Kay BH
J Am Mosq Control Assoc; 2001 Mar; 17(1):8-12. PubMed ID: 11345425
[TBL] [Abstract][Full Text] [Related]
9. Performance of ULV formulations (Pesguard 102/Vectobac 12AS) against three mosquito species.
Yap HH; Chong AS; Adanan CR; Chong NL; Rohaizat B; Malik YA; Lim SY
J Am Mosq Control Assoc; 1997 Dec; 13(4):384-8. PubMed ID: 9474567
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Bacillus thuringiensis israelensis, VectoBac WG and DT, formulations against dengue mosquito vectors in cement potable water jars in Cambodia.
Setha T; Chantha N; Socheat D
Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):261-8. PubMed ID: 17539275
[TBL] [Abstract][Full Text] [Related]
11. Field efficacy of granular formulations of Bacillus thuringiensis Israelensis--strain AM65-52 against floodwater mosquitoes in Poland and Germany.
Rydzanicz K; DeChant P; Becker N
J Am Mosq Control Assoc; 2010 Sep; 26(3):295-301. PubMed ID: 21033056
[TBL] [Abstract][Full Text] [Related]
12. Control of mosquitoes in catch basins in Connecticut with Bacillus thuringiensis israelensis, Bacillus sphaericus, [corrected] and spinosad.
Anderson JF; Ferrandino FJ; Dingman DW; Main AJ; Andreadis TG; Becnel JJ
J Am Mosq Control Assoc; 2011 Mar; 27(1):45-55. PubMed ID: 21476447
[TBL] [Abstract][Full Text] [Related]
13. Field evaluation of biolarvicides in Surat city, India.
Haq S; Bhatt RM; Vaishnav KG; Yadav RS
J Vector Borne Dis; 2004; 41(3-4):61-6. PubMed ID: 15672558
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of vectobac DT and culinexcombi against mosquito larvae in unused swimming pools in Malindi, Kenya.
Kahindi SC; Midega JT; Mwangangi JM; Kibe LW; Nzovu J; Luethy P; Githure J; Mbogo CM
J Am Mosq Control Assoc; 2008 Dec; 24(4):538-42. PubMed ID: 19181062
[TBL] [Abstract][Full Text] [Related]
15. Influence of temperature and concentration of VectoBac on control of the salt-marsh mosquito, Ochlerotatus squamiger, in Monterey County, California.
Christiansen JA; McAbee RD; Stanich MA; DeChant P; Boronda D; Cornel AJ
J Am Mosq Control Assoc; 2004 Jun; 20(2):165-70. PubMed ID: 15264626
[TBL] [Abstract][Full Text] [Related]
16. Comparative toxicity of selected larvicidal formulations against Anopheles stephensi Liston and Aedes aegypti Linn.
Mittal PK; Adak T; Batra CP
J Commun Dis; 2001 Jun; 33(2):116-20. PubMed ID: 12170930
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of three microbial formulations against Culex pipiens pipiens larvae in irrigation fields in Wroclaw, Poland.
Rydzanicz K; Lonc E; Kiewra D; Dechant P; Krause S; Becker N
J Am Mosq Control Assoc; 2009 Jun; 25(2):140-8. PubMed ID: 19653495
[TBL] [Abstract][Full Text] [Related]
18. Field trials of three concentrations of Laginex as biological larvicide compared to Vectobac-12AS as a biocontrol agent for Culex quinquefasciatus.
Hallmon CF; Schreiber ET; Vo T; Bloomquist A
J Am Mosq Control Assoc; 2000 Mar; 16(1):5-8. PubMed ID: 10757483
[TBL] [Abstract][Full Text] [Related]
19. Efficacy studies of Vectobac 12as and Teknar HP-D larvicides against 3rd-instar Ochlerotatus taeniorhynchus and Culex quinquefasciatus in small plot field studies.
Floore TG; Petersen JL; Shaffer KR
J Am Mosq Control Assoc; 2004 Dec; 20(4):429-33. PubMed ID: 15669386
[TBL] [Abstract][Full Text] [Related]
20. Laboratory and semi-field evaluation of the efficacy of
Derua YA; Tungu PK; Malima RC; Mwingira V; Kimambo AG; Batengana BM; Machafuko P; Sambu EZ; Mgaya YD; Kisinza WN
Curr Res Parasitol Vector Borne Dis; 2022; 2():100089. PubMed ID: 35664894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]